Literature DB >> 8186195

Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.

B Arunachalam1, C A Lamb, P Cresswell.   

Abstract

Major histocompatibility complex (MHC) class II molecules are heterodimers of alpha and beta subunits that associate intracellularly with the invariant chain. Human invariant chain exists in four forms, p33, p35, p41, and p43, generated by a combination of alternative initiation of translation and alternative splicing. The biological significance of the existence of the different forms of invariant chain is still unclear and to date no study has compared all four using one system. We have compared them for their transport characteristics and for their ability to transport associated MHC class II heterodimers into the endocytic pathway. Here we report that hetero oligomers containing p33 and p35 or p41 and p43 remain in the endoplasmic reticulum (ER) in the absence of class II alpha and beta chains. This is consistent with earlier reports suggesting that the N-terminal extension shared by p35 and p43 contains an ER retention signal. Homo oligomers containing only the p33 or p41 forms of invariant chain exit the ER and are sorted to endosomes following passage through the Golgi apparatus. Their accumulation leads to enlargement of the endosomes. Quantitation of the turnover rates of the p35/p33 forms with the alternatively spliced p43/p41 forms indicates that the latter are more stable, both in the ER and following transport through the Golgi apparatus. When class II molecules are co-expressed with p33 and p35, or p41 and p43, the assembled complex is efficiently transported to the endocytic pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8186195     DOI: 10.1093/intimm/6.3.439

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  20 in total

1.  Interaction of human immunodeficiency virus type 2 Vpx and invariant chain.

Authors:  H A Pancio; N Vander Heyden; K Kosuri; P Cresswell; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

3.  HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

Authors:  Marcel van Lith; Rosanna M McEwen-Smith; Adam M Benham
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 4.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

5.  Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.

Authors:  T Kuwana; P A Peterson; L Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 6.  Endosomal localization of MHC class II-invariant chain complexes.

Authors:  J Miller
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP).

Authors:  J T Karttunen; P J Lehner; S S Gupta; E W Hewitt; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 9.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

10.  The role of macrophage migration inhibitory factor in autoimmune liver disease.

Authors:  David N Assis; Lin Leng; Xin Du; Clarence K Zhang; Gerrit Grieb; Melanie Merk; Alvaro Baeza Garcia; Catherine McCrann; Julius Chapiro; Andreas Meinhardt; Yuka Mizue; David J Nikolic-Paterson; Jürgen Bernhagen; Marshall M Kaplan; Hongyu Zhao; James L Boyer; Richard Bucala
Journal:  Hepatology       Date:  2013-12-20       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.